A 62-year-old with COPD and frequent exacerbations despite maximal inhaled therapy asks about roflumilast. When is it considered?...

Question

A 62-year-old with COPD and frequent exacerbations despite maximal inhaled therapy asks about roflumilast. When is it considered?

Accepted Answer

In chronic bronchitis phenotype with frequent exacerbations and FEV1

Answer

In emphysema phenotype only

Answer

As first-line therapy

Answer

When eosinophils are high (>300/µL)

Answer

In asthma instead of ICS

us-abim MCQ (SBA): COPD